Germline Genetic Testing in Patients with Bone and Soft Tissue Sarcoma: A Prospective Multicenter Study to Evaluate Cancer Susceptibility
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26072839 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Isaak Ailts und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ 85054, USA. Hauptthemen laut MEDLINE: Germ-Line Mutation, Sarcoma, Genetic Predisposition to Disease, Genetic Testing. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mayo Transform the Practice Grant, Mayo Clinic Center for Individualized Medicine, Desert Mountain Members’ CARE Foundation, David and Twila Woods Foundation a….
Abstract (Originalsprache)
Sarcomas are rare heterogenous mesenchymal tumors with over seventy-five different subtypes, with varying biology and outcomes, with no clear inciting factor in the vast majority. To determine the prevalence of pathogenic germline variants (PGV) in patients with sarcomas, we undertook a prospective multi-site study of germline sequencing using an 84-gene next-generation sequencing panel among patients receiving care at the four Mayo Clinic Cancer Centers. Of 115 patients with bone and soft tissue sarcoma, the median age was 60 years, 49.6% were female, 82.6% were White. The anatomical location of the primary tumor included extremities (34.8%), retroperitoneum (19.1%), trunk (13.0%), and head and neck (7.8%). Family history of cancer was present in 62.6% of the study population. Ten patients (8.7%) had a pathogenic/likely pathogenic variant (PGV). Of these, three had stage IV sarcoma, and seven had earlier-stage sarcoma (stages I–III). Among the 55 (48.7%) patients who had variant of uncertain significance (VUS), 41.1% (22/55) had stage IV sarcoma and 58.9% (33/55) had earlier-stage disease. Of the ten patients with PGV, high-to-moderate penetrance gene abnormalities were identified in eight patients (80%) involving TP53 (3), BRCA1 (1), SDHA (1), ATM (2), and NBN (1) genes. The vast majority of the PGVs (70%) would not have been detected using the current guidelines. Because of the paucity of sarcomas and lack of effective treatment options for advanced disease, germline testing in sarcomas represents a potentially impactful strategy to assess therapeutic options and for assessment of familial risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ 85054, USA.
- Division of Hematology/Oncology, University of North Dakota, Fargo, ND 58122, USA.
- Department of Quantitative Health Sciences, Mayo Clinic, Phoenix, AZ 85043, USA.
- Department of Clinical Genomics, Mayo Clinic, Phoenix, AZ 85043, USA.
- Labcorp Genetics (formerly Invitae), San Francisco, CA 94103, USA.
- Division of Gastroenterology & Hepatology, Department of Medicine, Mayo Clinic, Phoenix, AZ 85054, USA.
ORCID-Profile: Isaak Ailts, Michael A Golafshar, Katie L Kunze, Edward D Esplin, Sarah Young
Förderung
- Mayo Transform the Practice Grant, Mayo Clinic Center for Individualized Medicine, Desert Mountain Members’ CARE Foundation, David and Twila Woods Foundation a…
Zitieren
APA
Ailts, I., Golafshar, M. A., Kunze, K. L., Klint, M., Barrus, K., Nussbaum, R. L., Esplin, E. D., Leach, B., Young, S., Samadder, N. J., & Seetharam, M. (2025). Germline Genetic Testing in Patients with Bone and Soft Tissue Sarcoma: A Prospective Multicenter Study to Evaluate Cancer Susceptibility. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26072839
Vancouver
Ailts I, Golafshar MA, Kunze KL, Klint M, Barrus K, Nussbaum RL, et al. Germline Genetic Testing in Patients with Bone and Soft Tissue Sarcoma: A Prospective Multicenter Study to Evaluate Cancer Susceptibility. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26072839
BibTeX
@article{Ailts2025,
author = {Ailts, Isaak and Golafshar, Michael A and Kunze, Katie L and Klint, Margaret and Barrus, Kathleen and Nussbaum, Robert L and Esplin, Edward D and Leach, Brandie and Young, Sarah and Samadder, N Jewel and Seetharam, Mahesh},
title = {Germline Genetic Testing in Patients with Bone and Soft Tissue Sarcoma: A Prospective Multicenter Study to Evaluate Cancer Susceptibility},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26072839}
}
EUVIMED